ALNY

Trade Alnylam Pharmaceuticals, Inc. - ALNY stock price

1m
5m
15m
30m
1H
4H
1D
1W
History

ALNY

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference (RNAi). Its pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, and hepatic infectious diseases. The company's clinical development programs include Patisiran, which is in Phase III clinical trial for the treatment of hereditary transthyretin-mediated amyloidosis; Givosiran that is in Phase III trial to treat acute hepatic porphyrias; Fitusiran, an investigational RNAi therapeutic that is in Phase II open-label extension and Phase III clinical trial for the treatment of hemophilia and rare bleeding disorders; and Inclisiran, which is in III clinical trial for hypercholesterolemia. Its clinical programs also include ALN-TTRsc02, an investigational RNAi therapeutic targeting TTR, which is in the Phase I clinical trial for the treatment of various forms of ATTR amyloidosis; Lumasiran (ALN-GO1) that is in Phase I/II clinical trial for the treatment of primary hyperoxaluria type 1; and Cemdisiran (ALN-CC5), which is in the Phase II clinical trial for the treatment of complement-mediated diseases. The company has strategic alliances primarily with Sanofi Genzyme; The Medicines Company; Monsanto Company; Takeda Pharmaceutical Company Limited; Ionis Pharmaceuticals, Inc; and Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Cambridge, Massachusetts.
White Paper Declaration
iPhone Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with crypto or fiat
iMac Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with crypto or fiat
iMac Image
1BTC
Invest
20BTC
Profit
Leverage:
x20
The Power Of Leverage
Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

ALNY price history

Date Close Change Change(%) Open High Low
Sep 21, 2021 183.64 0.02 0.01% 183.62 186.82 183.20
Sep 20, 2021 182.90 -3.17 -1.70% 186.07 187.44 181.54
Sep 17, 2021 189.79 -0.27 -0.14% 190.06 190.54 184.95
Sep 16, 2021 189.89 3.51 1.88% 186.38 191.56 185.38
Sep 15, 2021 187.26 0.19 0.10% 187.07 189.73 185.58
Sep 14, 2021 187.76 3.95 2.15% 183.81 189.49 183.10
Sep 13, 2021 185.33 -4.02 -2.12% 189.35 189.36 182.67
Sep 10, 2021 189.11 1.76 0.94% 187.35 192.16 187.35
Sep 9, 2021 189.10 4.20 2.27% 184.90 189.86 184.90
Sep 8, 2021 185.78 1.36 0.74% 184.42 188.66 183.95
Sep 7, 2021 187.84 -7.42 -3.80% 195.26 196.74 187.69
Sep 3, 2021 197.14 1.19 0.61% 195.95 199.43 195.95
Sep 2, 2021 199.88 1.11 0.56% 198.77 202.51 196.19
Sep 1, 2021 196.82 -2.34 -1.17% 199.16 200.81 196.34
Aug 31, 2021 200.88 -2.22 -1.09% 203.10 204.98 199.98
Aug 30, 2021 203.28 -0.04 -0.02% 203.32 207.56 200.74
Aug 27, 2021 203.69 2.60 1.29% 201.09 207.30 201.08
Aug 26, 2021 202.17 -1.63 -0.80% 203.80 206.51 202.16
Aug 25, 2021 204.49 5.58 2.81% 198.91 205.10 197.87
Aug 24, 2021 201.45 4.41 2.24% 197.04 202.15 195.51